PLBIO(SZ:000403) Shang Hai Zheng Quan Bao·2025-11-13 18:36Group 1 - The core point of the article is the announcement of the third extraordinary general meeting of shareholders of Pailin Biopharmaceutical Co., Ltd., which was held on November 13, 2025, and all proposed resolutions were approved without any objections [1][2][3]. Group 2 - The meeting was conducted both in-person and via online voting, with specific time slots for each method of participation [4][6]. - The location of the in-person meeting was specified as a conference room in Shanghai [5]. - The meeting was presided over by the chairman, Mr. Li Hao, and complied with relevant laws and regulations [6][9]. Group 3 - Two proposals were reviewed and approved during the meeting, with the voting results deemed valid and legal by the witnessing lawyers from Beijing Jiayuan Law Firm [8][9]. - The legal opinions confirmed that the meeting's procedures and voting were in accordance with the Company Law and the company's articles of association [9].